Identification of a novel motif in DNA ligases exemplified by DNA ligase IV

被引:19
作者
Marchetti, Caterina
Walker, Sarah A.
Odreman, Federico
Vindigni, Alessandro
Doherty, Aidan J. [1 ]
Jeggo, Penny
机构
[1] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN9 1RQ, E Sussex, England
[2] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
DNA ligases; LIG4; syndrome; DNA ligase structure; DNA repair; human syndromes;
D O I
10.1016/j.dnarep.2006.03.011
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
DNA ligase IV is an essential protein that functions in DNA non-homologous end-joining, the major mechanism that rejoins DNA double-strand breaks in mammalian cells. LIG4 syndrome represents a human disorder caused by mutations in DNA ligase IV that lead to impaired but not ablated activity. Thus far, five conserved motifs in DNA ligases have been identified. We previously reported G469E as a mutational change in a LIG4 syndrome patient. G469 does not lie in any of the previously reported motifs. A sequence comparison between DNA ligases led us to identify residues 468-476 of DNA ligase IV as a further conserved motif, designated motif Va, present in eukaryotic DNA ligases. We carried out mutational analysis of residues within motif Va examining the impact on adenylation, double-stranded ligation, and DNA binding. We interpret our results using the DNA ligase I:DNA crystal structure. Substitution of the glycine at position 468 with an alanine or glutamic acid severely compromises protein activity and stability. Substitution of G469 with an alanine or glutamic acid is better tolerated but still impacts upon activity and protein stability. These finding suggest that G468 and G469 are important for protein stability and provide insight into the hypomorphic nature of the G469E mutation identified in a LIG4 syndrome patient. In contrast, residues 470, 473 and 476 within motif Va can be changed to alanine residues without any impact on DNA binding or adenylation activity. Importantly, however, such mutational changes do impact upon double-stranded ligation activity. Considered in light of the DNA ligase I:DNA crystal structure, our findings suggest that residues 470-476 function as part of a molecular pincer that maintains the DNA in a conformation that is required for ligation. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:788 / 798
页数:11
相关论文
共 27 条
[1]   MUTATIONS IN THE DNA LIGASE-I GENE OF AN INDIVIDUAL WITH IMMUNODEFICIENCIES AND CELLULAR-HYPERSENSITIVITY TO DNA-DAMAGING AGENTS [J].
BARNES, DE ;
TOMKINSON, AE ;
LEHMANN, AR ;
WEBSTER, ADB ;
LINDAHL, T .
CELL, 1992, 69 (03) :495-503
[2]   Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice [J].
Barnes, DE ;
Stamp, G ;
Rosewell, I ;
Denzel, A ;
Lindahl, T .
CURRENT BIOLOGY, 1998, 8 (25) :1395-1398
[3]   A patient with mutations in DNA ligase IV: Clinical features and overlap with Nijmegen breakage syndrome [J].
Ben-Omran, TI ;
Cerosaletti, K ;
Concannon, P ;
Weitzman, S ;
Nezarati, MM .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 137A (03) :283-287
[4]   Structural and mechanistic conservation in DNA ligases [J].
Doherty, AJ ;
Suh, SW .
NUCLEIC ACIDS RESEARCH, 2000, 28 (21) :4051-4058
[5]   Characterization of proteolytic fragments of bacteriophage T7 DNA ligase [J].
Doherty, AJ ;
Ashford, SR ;
Wigley, DB .
NUCLEIC ACIDS RESEARCH, 1996, 24 (12) :2281-2287
[6]   Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV [J].
Frank, KM ;
Sekiguchi, JM ;
Seidl, KJ ;
Swat, W ;
Rathbun, GA ;
Cheng, HL ;
Davidson, L ;
Kangaloo, L ;
Alt, FW .
NATURE, 1998, 396 (6707) :173-177
[7]   DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains [J].
Grawunder, U ;
Zimmer, D ;
Lieber, MR .
CURRENT BIOLOGY, 1998, 8 (15) :873-876
[8]   X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes [J].
Hakansson, K ;
Doherty, AJ ;
Shuman, S ;
Wigley, DB .
CELL, 1997, 89 (04) :545-553
[9]  
Harrison C, 2002, CANCER RES, V62, P4065
[10]  
Jeggo PA, 2004, MOL B INT U, P146